Multibic

Sodium hydrogen carbonate, magnesium chloride hexahydrate, sodium chloride and calcium chloride dihydrate, the active ingredients in Multibic, are an electrolyte solution presented as a sterile solution for injection use. It provides electrolyte balance and buffering capacity for patients undergoing haemodialysis or requiring intravenous fluid replacement.

GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Multibic is used in renal replacement therapy to maintain electrolyte and acid‑base balance during haemodialysis and intravenous fluid replacement.

- Renal failure requiring haemodialysis: restores sodium, chloride, magnesium and calcium levels while providing buffering capacity. - Electrolyte replacement: corrects acute deficits of key electrolytes in patients with fluid loss or metabolic disturbances. - Intravenous fluid replacement: supplies isotonic fluid for patients unable to maintain intravascular volume.

Multibic may be associated with infusion‑related reactions and electrolyte shifts.

Common Side Effects: - Infusion site pain or erythema: mild discomfort at the catheter site. - Transient hypernatremia: temporary rise in serum sodium levels. - Nausea or mild gastrointestinal upset. - Headache: often related to rapid fluid shifts. - Mild hypotension: drop in blood pressure during rapid infusion. - Fever or chills: low‑grade febrile response.

Serious or Rare Side Effects: - Severe hypermagnesemia: can cause muscle weakness, respiratory depression. - Severe hypercalcemia: may lead to cardiac arrhythmias. - Anaphylactic reaction: rare but potentially life‑threatening hypersensitivity. - Cardiac arrhythmia: due to abrupt electrolyte changes. - Metabolic alkalosis: excessive bicarbonate load. - Pulmonary edema: from volume overload in susceptible patients.

When using Multibic, clinicians should observe several safety measures.

- Baseline electrolyte assessment: verify serum sodium, potassium, calcium and magnesium before infusion. - Cardiac monitoring: observe rhythm during and after administration, especially in patients with cardiac disease. - Dose adjustment in renal impairment: reduce volume or concentration as needed. - Avoid in hypercalcemia: high calcium content may exacerbate the condition. - Pregnancy and lactation: safety not established; use only if clearly needed. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Multibic can interact with other agents that affect electrolyte balance or acid‑base status.

Major Interactions (Avoid): - Concurrent calcium‑containing solutions: risk of precipitation and hypercalcemia. - High‑dose magnesium sulfate: may cause severe hypermagnesemia. - Additional bicarbonate agents: can precipitate metabolic alkalosis. - Loop diuretics: may intensify electrolyte loss. - ACE inhibitors or ARBs: increase risk of hyperkalemia when combined with other electrolyte solutions.

Moderate Interactions (Monitor Closely): - Sodium‑rich medications: monitor for hypernatremia. - Anticoagulants used during dialysis: watch for altered clotting parameters. - Blood pressure‑lowering drugs: observe for additive hypotensive effects.